What Is Digital PCR? Principles of dPCR and Current Research Applications
11 min read••By Chemical Express Thailand

Your qPCR assay is giving you cycle threshold values near the detection limit, and you cannot tell whether that signal is real or noise. Rare variants, inhibitor-heavy matrices, and the absence of a reliable standard curve make low-copy quantification genuinely unreliable. This article explains what is digital PCR dPCR, how it works mechanically and statistically, and where it delivers a clear advantage over qPCR in real research workflows.
What is digital PCR, and how is dPCR different from qPCR?
What is digital PCR dPCR? It is an end-point PCR method that splits a single reaction into thousands to millions of discrete microreactions called partitions. Each partition either amplifies or does not. You count the positives, apply a statistical correction, and calculate absolute copy number without a standard curve.
That distinction matters operationally. qPCR measures fluorescence kinetics during amplification and relies on a calibrated standard to back-calculate concentration. dPCR skips that dependency entirely. It also tolerates PCR inhibitors better, because each partition acts as an independent micro-environment where partial inhibition shifts a partition from positive to negative rather than distorting the entire reaction curve.
The phrase "what is digital PCR dPCR" uses both terms interchangeably: digital PCR is the full name; dPCR is the abbreviation used in instrument nomenclature and kit documentation.
One trade-off is worth stating plainly. dPCR throughput is lower than qPCR, and per-sample cost is higher. That shapes method selection: use qPCR for routine screening and reserve dPCR for confirmatory assays, rare allele detection, or studies where absolute copy number is the primary endpoint.
How dPCR works: partitioning, end-point reads, and Poisson statistics
Partitioning and detection
The workflow begins by combining your template, primers, hydrolysis probe or intercalating dye, polymerase, and buffer. That reaction mix is then partitioned, either into water-in-oil droplets using a droplet generator, or into fixed microwells etched onto a chip. The assembly thermocycles to end-point. No fluorescence is monitored during cycling; you read each partition only after amplification is complete.
Droplet-based systems typically generate 10,000 to 20,000 droplets per reaction. Chip-based systems use fixed microwell arrays, ranging from tens of thousands to millions of chambers per run. Droplet platforms handle low-viscosity samples well and scale easily. Chip platforms offer higher partition counts per reaction and can be more tolerant of sample-to-sample variation in droplet formation, but generally require matched chip consumables and dedicated readers.
After thermocycling, a reader scans each partition and records fluorescence amplitude. Partitions above the threshold score as positive; those below score as negative. The separation between positive and negative clusters is a direct measure of assay quality. Poorly designed probes or mismatched quenchers compress that gap and increase classification errors, which is why probe chemistry and amplicon length both affect data integrity.
Statistics and dynamic range
Once positive and negative counts are recorded, concentration is calculated using the Poisson equation: lambda equals negative ln of (1 minus p), where p is the fraction of positive partitions. Lambda represents the average number of molecules per partition. Multiply lambda by the total number of partitions and divide by the total reaction volume to obtain copies per unit volume.
Precision improves with more total partitions and more positive events. Running replicates or merging data across multiple wells narrows confidence intervals at low copy numbers. At very low fractional abundance, such as rare alleles below 0.1 percent, the total number of positive events becomes the limiting factor for statistical certainty, regardless of how many total partitions are counted.
| Platform type | Typical partitions per reaction | Recommended positive rate | Approximate dynamic range | Typical LOD (copies/reaction) |
|---|---|---|---|---|
| Droplet dPCR | 10,000 to 20,000 | 10 to 70% | 4 to 5 logs | 1 to 5 |
| Chip dPCR (mid-density) | 20,000 to 100,000 | 10 to 70% | 4 to 5 logs | 1 to 3 |
| Chip dPCR (high-density) | 100,000 to 1,000,000+ | 10 to 70% | 5 to 6 logs | less than 1 |
Note that values above are typical ranges reported across published platforms. Actual performance depends on assay design, template quality, and instrument specification. Always validate LOD empirically for your specific target and matrix.
For a broader grounding in PCR principles before applying dPCR, this overview of PCR fundamentals covers amplification mechanics and common workflow considerations.
Key assay components, controls, and data-quality checkpoints
Core reagents and RT-dPCR add-ons
Reliable dPCR starts with reagent selection. You need a hot-start or high-fidelity DNA polymerase validated for end-point partitioned reactions, dPCR-compatible buffers, and hydrolysis probes designed for tight cluster separation. ROX passive reference dye is required by some instrument platforms for signal normalisation. Reference materials or certified standards allow copy accuracy checks across runs.
For RNA targets, add a reverse transcription step. One-step RT-dPCR kits integrate cDNA synthesis and amplification in a single tube, which reduces handling steps and cross-contamination risk. When archival or fixed samples carry carryover RNA from previous amplifications, include uracil-N-glycosylase (UNG) to degrade contaminating amplicons before cycling begins.
Merck's PCR Reagents & Kits portfolio covers this full reagent landscape. The KOD Hot Start DNA Polymerase and KOD One PCR Master Mix lines provide high-fidelity amplification that reduces off-target background, which tightens the separation between positive and negative droplet clusters. The FastStart Universal Probe Master (Rox) supports probe-based detection and includes ROX normalisation, making it compatible with readers that require passive reference channels. These products reduce reagent troubleshooting time so labs can focus optimisation effort on assay design rather than polymerase performance.
Quick tips
- Design amplicons under 150 bp to improve efficiency in inhibitor-prone matrices.
- Use MGB or LNA-modified probes when discriminating single-nucleotide variants.
- Check surfactant compatibility: some detergents destabilise droplets during partitioning.
- Minimise pipetting steps after partition generation to reduce droplet coalescence and loss.
- Target template input at a concentration that yields 20 to 60 percent positive partitions for most quantitative applications.
Controls and data-quality checkpoints
Run a no-template control (NTC) in every batch to flag reagent contamination. Include extraction blanks alongside sample-matched controls to detect inhibitors introduced during nucleic acid isolation. A spike-in internal positive control (IPC) at a fixed copy number identifies inhibition within individual reactions. Positive reference controls at known concentrations anchor copy-number accuracy across batches.
Before accepting results, verify that each well meets minimum partition count thresholds, that positive fraction sits within the acceptable range, and that cluster separation metrics pass the instrument's quality flags. Confidence intervals wider than your biological threshold signal insufficient positive events and call for repeat runs with higher template input or more replicates.
| Parameter | Recommended range or criterion | Action if out of range |
|---|---|---|
| Positive partition fraction | 10 to 70% | Dilute sample or increase input |
| Total accepted partitions | Above platform minimum (typically 10,000+) | Repeat well or merge replicates |
| Cluster separation (rain) | Clean gap between positive and negative clusters | Optimise probe or annealing temperature |
| NTC positive partitions | Zero or within background specification | Investigate contamination source |
| IPC copy recovery | Within 20% of expected value | Check inhibition; repeat extraction |
Quick decision guide: dPCR vs qPCR vs NGS for your quantification need
- You need absolute copies without a standard curve
- Target allele frequency is below 1 percent
- Sample matrix carries PCR inhibitors
- Confirmatory quantification of CNVs or viral loads is required
- Regulatory or clinical submission demands high precision at low copy numbers
- High throughput with relative quantification is sufficient
- Broad multiplex panels across many targets are needed
- Per-sample cost must stay low for routine screening
- Standard curves from validated references are available and stable
- Discovery of unknown variants is the primary goal
- Whole-genome or whole-transcriptome coverage is needed
- Multiplexing hundreds of targets simultaneously is required
- dPCR is used downstream to confirm specific NGS findings
Current research applications where dPCR adds clear value
Oncology and minimal residual disease
Liquid biopsy for circulating tumour DNA (ctDNA) is one of dPCR's strongest use cases. Tumour-derived alleles can represent a fraction of a percent of total cell-free DNA. qPCR cannot reliably distinguish signal from background at those ratios. dPCR counts each mutant partition independently, so low-frequency mutations, copy number variants, and fusion transcripts become quantifiable with statistical confidence rather than inference from a Ct value near the noise floor.
Minimal residual disease (MRD) monitoring in haematology follows the same logic. A single residual tumour cell in a background of thousands of normal cells produces a fractional signal that Poisson-corrected partition counting can resolve where curve-based qPCR cannot.
Infectious disease and virology
Viral load quantification has traditionally relied on qPCR standards that drift between kit lots. dPCR provides lot-independent absolute titers, which simplifies inter-laboratory comparisons and reduces uncertainty when standards are unavailable or expensive. Wastewater epidemiology benefits particularly: environmental matrices carry inhibitors that distort qPCR Ct values but affect each dPCR partition independently, preserving the overall positive fraction and the downstream copy calculation.
Allele-specific probes enable variant discrimination within a single reaction well. For respiratory pathogens or emerging variants with single-nucleotide differences, this provides faster actionable data than sequencing-based confirmation.
Gene therapy and cell therapy
Regulatory filings for AAV and lentiviral products typically require vector copy number per cell and residual DNA quantification at defined limits. dPCR delivers the absolute titering accuracy these submissions demand, and it does so without relying on reference standards that may not yet exist for novel constructs. Measuring integration copy number in transduced cell populations is another application where partition counting outperforms relative qPCR.
Food, environmental, and GMO testing
Regulatory GMO thresholds are defined as percent composition. Measuring those percentages accurately in complex food matrices requires a quantification method that survives extraction variability and inhibitor carry-over. dPCR handles both without recalibration between sample types. Absolute counts also remove the lot-to-lot variation in reference standards that complicates qPCR-based compliance testing.
NGS library support and orthogonal confirmation
Library molarity before sequencer loading directly affects cluster density and data quality. dPCR provides absolute library quantification without the standard-curve uncertainty that affects fluorometric or qPCR-based methods. After sequencing, dPCR can confirm rare variant calls orthogonally, reducing false-positive reporting in clinical or regulatory contexts. For more on integrating these quantification checkpoints into your NGS workflow, see this guide to library preparation steps and kits.
| Application | Target type | Sample matrix | Typical copy range | Recommended partition depth |
|---|---|---|---|---|
| ctDNA / liquid biopsy | SNV, CNV, fusion | Cell-free plasma DNA | 1 to 1,000 copies/mL | High (100,000+) |
| Viral load (clinical) | Viral genome | Plasma, serum, CSF | 10 to 10^7 copies/mL | Standard (10,000 to 20,000) |
| Wastewater surveillance | Viral RNA/DNA | Concentrated wastewater | 10 to 10^5 copies/reaction | Standard with replicates |
| Vector copy number (gene therapy) | Transgene insert | Genomic DNA from transduced cells | 0.1 to 20 copies/cell | Standard to high |
| GMO quantification | Transgenic event | Extracted food/feed DNA | 0.1 to 5% of total | Standard |
| NGS library quantification | Adapter-ligated fragments | Purified library | 1 to 100 nM | Standard |
Summary: when to choose dPCR for your lab
Revisiting the core question, what is digital PCR dPCR, through a method-selection lens: it is the right tool when your decision depends on precise low-level quantification, rare allele detection, or inhibitor resilience. At those thresholds, Poisson-corrected partition counting gives you higher confidence than curve-dependent qPCR.
For high-throughput screening or broad multiplex discovery, qPCR or NGS is more efficient. The practical hybrid strategy is to screen broadly with qPCR or NGS, then confirm or characterise low-level or ambiguous findings with dPCR. That keeps per-sample costs aligned with the value each method actually adds to your workflow.
Reagent reliability underpins both legs of that hybrid approach. Merck's PCR Reagents & Kits range, including hot-start master mixes and probe-based qPCR reagents available through Chemical Express Thailand, supports consistent amplification across both screening and confirmatory steps, reducing the variable that most often undermines reproducibility at low copy numbers.
Frequently asked questions
Recommended Products
All products below are available through Chemical Express Thailand. Submit an inquiry for pricing, availability, or technical guidance.
Recommended Products Available at Chemical Express
We deliver a wide range of Advanced PCR & Sequencing products from Merck and MedChemExpress (MCE) and other international brands across Thailand. For any inquiry or purchase, fill out our Inquiry Form or chat with us instantly on Line.